Aberdeen India Fund

IFN

Börsenwert 458 Mio. $

Aberdeen India Fund, a CEF that focuses on around 50 Indian stocks, has faced a rough 15 months, but I am prepared to turn cautiously optimistic on it now. Renewed foreign portfolio inflows, regulatory reforms, a wider-than-normal 9.5% discount to NAV, and a boost in its managed distribution policy all enhance the bull case. The risk-reward on the long-term charts too looks enticing, with IFN showing some signs of stabilization in recent months.

PHILADELPHIA, May 11, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on May 29, 2026 to all shareholders of record as of May 21, 2026 (ex-dividend date May 21, 2026). The abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), and the India Fund, Inc. (IFN) will pay their distributions on June 30, 2026, to shareholders of record as of May 21, 2026 (ex‑dividend date May 21, 2026).

PHILADELPHIA, March 31, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, HQH, HQL, IFN, THQ), (NYSE American: IAF) (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on March 31, 2026, on a per share basis to all shareholders of record as of March 24, 2026 (ex-dividend date March 24, 2026). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and Aberdeen India Fund Inc. (IFN) which paid on March 31, 2026, to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026).

IFN, an ETF focused on Indian equities, has significantly underperformed the S&P 500, risk-free US returns, and even Indian benchmarks on a currency-adjusted basis. The recent energy spikes have resulted in further pressure on domestic equities and the currency. Elevated oil prices directly affect the current account balance, along with an impact on GDP. IFN is rated as a sell, rising energy prices act as a negative for equities while persistent currency depreciation erodes USD-denominated returns, making broad-based Indian equity exposure unattractive for now.

PHILADELPHIA, Feb. 10, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, FCO, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on February 27, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on March 31, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026).

The India Fund Inc remains unattractive due to persistent high valuations and underperformance versus peers and benchmarks. Despite India's robust economic growth and strong consumer sentiment, IFN's portfolio trades at a PE above 30, exceeding the MSCI India Index. Recent tariff risks, geopolitical uncertainty, and a narrow 3% discount to NAV heighten the risk of further discount widening.

PHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, HQH, HQL, IFN, THQ), (NYSE American: IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on January 12, 2026, on a per share basis to all shareholders of record as of December 31, 2025 (ex-dividend date December 31, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on January 12, 2026, to all shareholders of record as of November 21, 2025 (ex-dividend date November 21, 2025).

PHILADELPHIA , Dec. 9, 2025 /PRNewswire/ -- The Board of Directors of The India Fund, Inc. (NYSE: IFN) has approved a 20% increase in the Fund's managed distribution policy. The fund will pay its quarterly distributions at an annualized rate of 12%, based on the average daily NAV of the previous three calendar months prior to the declaration date.

PHILADELPHIA , Nov. 11, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, FCO, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on November 28, 2025 to all shareholders of record as of November 21, 2025 (ex-dividend date November 21, 2025). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on January 12, 2026, to all shareholders of record as of November 21, 2025 (ex-dividend date November 21, 2025).

IFN offers exposure to India's long-term growth driven by demographics, consumption, and structural reforms, though current market consolidation and valuation pressures demand cautious positioning. The fund's ~11.5% yield is attractive but largely fueled by capital appreciation, making sustainability dependent on continued Indian market performance and active management success. IFN provides partial diversification benefits for U.S. investors, though correlations with global markets remain high, limiting defensive appeal except during brief geopolitical or macro dislocations.